4 Apr 2012

UCB and Amgen Initiate Sclerostin Antibody Phase 3 program in patients with postmenopausal osteoporosis

Read More
3 Apr 2012

Neupro® approved by U.S. FDA for Parkinson’s Disease and Restless Legs Syndrome

Read More
29 Mar 2012

Acquisition of own shares in the framework of employees’ long-term incentive plans

Read More
22 Mar 2012

Acquisition of own shares

Read More
22 Mar 2012

New members on UCB's Board of Directors

Read More
20 Mar 2012

Transparency notification of Pharmahold SA

Read More
19 Mar 2012

Industry and academia join forces as UCB and Oxford University announce new R&D partnership

Read More
15 Mar 2012

Acquisition of own shares in the framework of employees’ long-term incentive plans

Read More
8 Mar 2012

Acquisition of own shares in the framework of employees’ long-term incentive plans

Read More
7 Mar 2012

UCB CEO to chair Innovative Medicines Initiative board

Read More
Subscribe to